Roche Research Center
Hoffmann-La Roche Inc.
David Fry is a research scientist at the Hoffmann-La Roche Research Center in Nutley, NJ. In this interview, Dr. Fry discusses his work on the development of cancer drugs that target protein:protein interactions. Specifically, his work is directed at disrupting the interaction between the p53 and MDM2 proteins.